Cytomegalovirus in the Neonate: Immune Correlates of Infection and Protection

Fetal and neonatal infections caused by human cytomegalovirus (CMV) are important causes of morbidity and occasional mortality. Development of a vaccine against congenital CMV infection is a major public health priority. Vaccine design is currently focused on strategies that aim to elicit neutrali...

Full description

Saved in:
Bibliographic Details
Main Author: Mark R. Schleiss
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Clinical and Developmental Immunology
Online Access:http://dx.doi.org/10.1155/2013/501801
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832552130582413312
author Mark R. Schleiss
author_facet Mark R. Schleiss
author_sort Mark R. Schleiss
collection DOAJ
description Fetal and neonatal infections caused by human cytomegalovirus (CMV) are important causes of morbidity and occasional mortality. Development of a vaccine against congenital CMV infection is a major public health priority. Vaccine design is currently focused on strategies that aim to elicit neutralizing antibody and T-cell responses, toward the goal of preventing primary or recurrent infection in women of child-bearing age. However, there has been relatively little attention given to understanding the mechanisms of immune protection against acquisition of CMV infection in the fetus and newborn and how this information might be exploited for vaccine design. There has similarly been an insufficient study of what deficits in the immune response to CMV, both for mother and fetus, may increase susceptibility to congenital infection and disease. Protection of the fetus against vertical transmission can likely be achieved by protection of the placenta, which has its own unique immunological milieu, further complicating the analysis of the correlates of protective immunity. In this review, the current state of knowledge about immune effectors of protection against CMV in the maternal, placental, and fetal compartments is reviewed. A better understanding of immune responses that prevent and/or predispose to infection will help in the development of novel vaccine strategies.
format Article
id doaj-art-0218a4f2766045f3acd5323f098dfdc1
institution Kabale University
issn 1740-2522
1740-2530
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Clinical and Developmental Immunology
spelling doaj-art-0218a4f2766045f3acd5323f098dfdc12025-02-03T05:59:26ZengWileyClinical and Developmental Immunology1740-25221740-25302013-01-01201310.1155/2013/501801501801Cytomegalovirus in the Neonate: Immune Correlates of Infection and ProtectionMark R. Schleiss0Department of Pediatrics, University of Minnesota Medical School, Center for Infectious Diseases and Microbiology Translational Research, 2001 6th Street SE, Minneapolis, MN 55455, USAFetal and neonatal infections caused by human cytomegalovirus (CMV) are important causes of morbidity and occasional mortality. Development of a vaccine against congenital CMV infection is a major public health priority. Vaccine design is currently focused on strategies that aim to elicit neutralizing antibody and T-cell responses, toward the goal of preventing primary or recurrent infection in women of child-bearing age. However, there has been relatively little attention given to understanding the mechanisms of immune protection against acquisition of CMV infection in the fetus and newborn and how this information might be exploited for vaccine design. There has similarly been an insufficient study of what deficits in the immune response to CMV, both for mother and fetus, may increase susceptibility to congenital infection and disease. Protection of the fetus against vertical transmission can likely be achieved by protection of the placenta, which has its own unique immunological milieu, further complicating the analysis of the correlates of protective immunity. In this review, the current state of knowledge about immune effectors of protection against CMV in the maternal, placental, and fetal compartments is reviewed. A better understanding of immune responses that prevent and/or predispose to infection will help in the development of novel vaccine strategies.http://dx.doi.org/10.1155/2013/501801
spellingShingle Mark R. Schleiss
Cytomegalovirus in the Neonate: Immune Correlates of Infection and Protection
Clinical and Developmental Immunology
title Cytomegalovirus in the Neonate: Immune Correlates of Infection and Protection
title_full Cytomegalovirus in the Neonate: Immune Correlates of Infection and Protection
title_fullStr Cytomegalovirus in the Neonate: Immune Correlates of Infection and Protection
title_full_unstemmed Cytomegalovirus in the Neonate: Immune Correlates of Infection and Protection
title_short Cytomegalovirus in the Neonate: Immune Correlates of Infection and Protection
title_sort cytomegalovirus in the neonate immune correlates of infection and protection
url http://dx.doi.org/10.1155/2013/501801
work_keys_str_mv AT markrschleiss cytomegalovirusintheneonateimmunecorrelatesofinfectionandprotection